Charles M. Haskell
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer survivorship and care
-
- Monoclonal and Polyclonal Antibodies Research
- Radiopharmaceutical Chemistry and Applications
Papers in
- Oncology 24
- Cancer Treatment and Pharmacology 8
- Lung Cancer Research Studies 5
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 3
- Co-authors
- George P. CanellosRobert A. FiglinJessie SiauMagali SchreyerS CarrelPaul P. CarboneArthur A. SerpickDonald L. Morton
- Journals
- Current Problems in Cancer (8 papers)Cancer (5 papers)Journal of Clinical Oncology (3 papers)The Lancet (2 papers)New England Journal of Medicine (2 papers)
- Partner nations
- United StatesFranceSwitzerland
In The Last Decade
Charles M. Haskell
49 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 118
- Oncology 786
- Radiology, Nuclear Medicine and Imaging 365
- Cancer Research 207
- Physiology 61
- Pediatrics, Perinatology and Child Health 247
Countries citing papers authored by Charles M. Haskell
This map shows the geographic impact of Charles M. Haskell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Haskell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Haskell more than expected).
Fields of papers citing papers by Charles M. Haskell
This network shows the impact of papers produced by Charles M. Haskell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Haskell. The network helps show where Charles M. Haskell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles M. Haskell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 32 | |
| 2 | 2009 | 53 | |
| 3 | 2006 | 54 | |
| 4 | 2006 | 3 | |
| 5 | 1998 | 46 | |
| 6 | 1996 | 41 | |
| 7 | 1991 | 51 | |
| 8 | 1991 | 1 | |
| 9 | 1989 | 151 | |
| 10 | 1988 | 22 | |
| 11 | 1988 | 162 | |
| 12 | Carcinoembryonic Antigen in Breast Cancer | 1988 | 21 |
| 13 | 1988 | 9 | |
| 14 | 1984 | 30 | |
| 15 | 1983 | 213 | |
| 16 | 1977 | 18 | |
| 17 | 1974 | 28 | |
| 18 | L-asparaginase toxicity. | 1969 | 65 |
| 19 | 1969 | 3 | |
| 20 | 1969 | 56 |
About Charles M. Haskell
Charles M. Haskell is a scholar working on Oncology, Physiology, Transplantation, Pathology and Forensic Medicine and Cancer Research, having authored 50 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Acute Lymphoblastic Leukemia research (8 papers), Lung Cancer Research Studies (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Childhood Cancer Survivors' Quality of Life (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer-related Molecular Pathways (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (786 citations), Radiology, Nuclear Medicine and Imaging (365 citations), Cancer Research (207 citations), Physiology (61 citations) and Pediatrics, Perinatology and Child Health (247 citations). Charles M. Haskell has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include George P. Canellos, Robert A. Figlin, Jessie Siau, Magali Schreyer, S Carrel, Paul P. Carbone, Arthur A. Serpick, Donald L. Morton, John S. Hunt and Melvin J. Silverstein. Their work appears in journals such as Current Problems in Cancer, Cancer, Journal of Clinical Oncology, The Lancet and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.